StockNews.AI
SNES
StockNews.AI
141 days

SenesTech to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025

1. SenesTech to participate in Lytham Partners Investor Summit on April 1, 2025. 2. New case study expected to showcase Evolve’s success in almond orchards. 3. Optimization efforts could reduce annual expenses by $2 million. 4. Target for cash flow breakeven could drop to $7 million annually. 5. Company expects transformational advancements leading toward profitability.

7m saved
Insight
Article

FAQ

Why Bullish?

The expected cost reductions and breakeven adjustments signal improved financial health, similar to historic turnarounds seen in early biotech companies after effective cost management.

How important is it?

SenesTech’s strategic updates signifying potential profitability and improved operations align directly with investor interests.

Why Long Term?

The anticipated shift in operational efficiencies and new case study highlights potential growth trajectories, which could unfold over several quarters.

Related Companies

CARRTRPAVAV
, /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, today announced that it will participate in a webcast fireside chat at the Lytham Partners 2025 Industrials & Basic Materials Investor Summit, taking place virtually on Tuesday, April 1, 2025. The fireside chat will take place at 3:00 p.m. ET on Tuesday, April 1, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/ibmsummit25/ or directly at https://lythampartners.com/ibmsummit25/snes/. A replay of the fireside chat will be available through the same links. 1x1 investor meetings will be available after the event upon request by contacting a Lytham Partners representative at [email protected]. About SenesTech SenesTech is committed to creating healthier environments by humanely managing animal pest populations through fertility control. The Company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective, and sustainable. For more information visit https://senestech.com/. Safe Harbor Statement This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our expectation that a new case study will be published detailing the success of Evolve in almond orchards, including a finding that by slowly placing the Evolve bait further away from the trees it actually lured the rats away from the crop altogether, highlighting the rat's fondness for the fertility control product; our expectation that our new optimization efforts will further reduce expenses by $2 million on an annualized basis; our anticipation that when coupled with lower cost of goods sold, the new optimization efforts will reduce the revenue target for cash flow breakeven to approximately $7 million annually, compared to $12 million historically; our belief that 2024 has been a transformational year with strong financial results; our belief that the increase in quarterly revenues and quarterly gross margins, coupled with improvement in our operational efficiencies through cost reduction resulted in our smallest quarterly Adjusted EBITDA loss in Company history; our belief that we are advancing towards profitability; our commitment to execute a focused strategy that positions us for sustainable long-term success; our belief that by concentrating on our most impactful growth areas, improving cost-efficiency, and streamlining operations, we are taking decisive steps to accelerate our path to profitability; and our belief that we are well positioned to transform the rodent control market for years to come due to our first mover advantage with a disruptive approach to the multi-billion dollar rodent control market. Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to maintain compliance with Nasdaq's continued listing requirements; regulatory approval and regulation of our products; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise. CONTACT:  Investor Relations: Robert Blum, Lytham Partners, LLC, 602-889-9700, [email protected] Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143 SOURCE SenesTech, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News